BTG1 (BTG anti-proliferation factor 1) functions as a tumor suppressor protein that critically regulates cell proliferation and maintains cellular quiescence. The protein serves as an immune gatekeeper mechanism that limits B cell fitness during antibody affinity maturation in germinal centers 1. BTG1 maintains quiescence in hematopoietic stem cells and naive/memory T cells, highlighting its role in preserving the quiescent state 2. The protein operates through multiple mechanisms including transcriptional regulation, post-transcriptional control, and translation modulation 2. In CD8+ T cell differentiation, BTG1 acts as a cell stress regulator that plays a key role in establishing exhausted T cell populations during chr12 infection 3. BTG1 deletions are frequently observed in B-cell malignancies and acute lymphoblastic leukemia, where they contribute to poor prognosis profiles 45. In cancer immunotherapy, BTG1 upregulation is associated with hyporesponsiveness in CAR-NKT cells, and BTG1 knockdown enhances anti-tumor activity in neuroblastoma models 6. Mutations disrupting BTG1 function convert germinal center B cells into 'supercompetitors' that can lead to aggressive lymphomas, demonstrating the delicate balance between immune selection and malignant transformation 1.